litlas
Log inCreate account

Frank M. LaFerla

Active 1995–2025

169
Papers
44,470
Citations
109
h-index
167
i10-index

Citations

Citations per year for Frank M. LaFerla1962: 1 citations1992: 1 citations1995: 8 citations1996: 24 citations1997: 31 citations1998: 24 citations1999: 13 citations2000: 59 citations2001: 49 citations2002: 91 citations2003: 79 citations2004: 179 citations2005: 216 citations2006: 344 citations2007: 421 citations2008: 555 citations2009: 600 citations2010: 946 citations2011: 893 citations2012: 930 citations2013: 805 citations2014: 865 citations2015: 788 citations2016: 803 citations2017: 673 citations2018: 713 citations2019: 1,748 citations2020: 1,869 citations2021: 1,775 citations2022: 1,278 citations2023: 1,024 citations2024: 1,273 citations2025: 685 citations2026: 6 citations1963–1991: no citations, so these years are not shown1993–1994: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 5,847 citing papers, 28.7% of this breakdownChina: 2,109 citing papers, 10.3% of this breakdownUnited Kingdom: 1,133 citing papers, 5.6% of this breakdownItaly: 939 citing papers, 4.6% of this breakdownGermany: 919 citing papers, 4.5% of this breakdownCanada: 760 citing papers, 3.7% of this breakdownSpain: 611 citing papers, 3% of this breakdownIndia: 592 citing papers, 2.9% of this breakdownJapan: 554 citing papers, 2.7% of this breakdownAustralia: 531 citing papers, 2.6% of this breakdownFrance: 531 citing papers, 2.6% of this breakdownSouth Korea: 531 citing papers, 2.6% of this breakdown
0%28.7%Other 26.2%

Institutions

Fields

  • Medicine54.4%
  • Neuroscience20.3%
  • Biochemistry, Genetics and Molecular Biology18.7%
  • Nursing1.7%
  • Immunology and Microbiology1%
  • Computer Science0.9%
  • Other3%

Topics

  • Alzheimer's disease research and treatments17.9%
  • Neuroinflammation and Neurodegeneration Mechanisms6.3%
  • Cholinesterase and Neurodegenerative Diseases4.4%
  • Neuroscience and Neuropharmacology Research3.9%
  • Tryptophan and brain disorders3%
  • Computational Drug Discovery Methods2.8%
  • Other61.7%

Coauthors

All papers

Open in search
  1. Alzheimer's Disease

    Authors: Henry Querfurth, Frank M. LaFerla - New England Journal of Medicine 2010 cited by 4,454

  2. Triple-Transgenic Model of Alzheimer's Disease with Plaques and Tangles

    Authors: Salvatore Oddo, Antonella Caccamo, Jason D. Shepherd, M. Paul Murphy, Todd E. Golde, Rakez Kayed, Raju Metherate, Mark P. Mattson, Yama Akbari, Frank M. LaFerla - Neuron 2003 cited by 4,130

  3. The Role of Tau in Alzheimer's Disease and Related Disorders

    Authors: Rodrigo Medeiros, David Baglietto‐Vargas, Frank M. LaFerla - CNS Neuroscience & Therapeutics 2010 cited by 418

  4. Intracellular amyloid-β in Alzheimer's disease

    Authors: Frank M. LaFerla, Kim N. Green, Salvatore Oddo - Nature reviews. Neuroscience 2007 cited by 1,932

  5. Early long-term administration of the CSF1R inhibitor PLX3397 ablates microglia and reduces accumulation of intraneuronal amyloid, neuritic plaque deposition and pre-fibrillar oligomers in 5XFAD mouse model of Alzheimer’s disease

    Authors: Justyna Sosna, Stephan Philipp, Ricardo Albay, Jorge Mauricio Reyes‐Ruiz, David Baglietto‐Vargas, Frank M. LaFerla, Charles Glabe - Molecular Neurodegeneration 2018 cited by 410

  6. Systematic Phenotyping and Characterization of the 3xTg-AD Mouse Model of Alzheimer’s Disease

    Authors: Dominic I. Javonillo, Kristine M. Tran, Jimmy Phan, Edna E. Hingco, Enikö A. Kramár, Celia da Cunha, Stefânia Forner, Shimako Kawauchi, Giedre Milinkeviciute, Ángela Gómez-Arboledas, Jonathan Neumann, Crystal E. Banh, Michelle Huynh, Dina P. Matheos, Narges Rezaie, Joshua A. Alcantara, A Mortazavi, Marcelo A. Wood, Andrea J. Tenner, Grant R. MacGregor, Kim N. Green, Frank M. LaFerla - Frontiers in Neuroscience 2022 cited by 212

  7. Blocking IL-1 Signaling Rescues Cognition, Attenuates Tau Pathology, and Restores Neuronal β-Catenin Pathway Function in an Alzheimer’s Disease Model

    Authors: Masashi Kitazawa, David Cheng, Michelle R. Tsukamoto, Maya A. Koike, Paul D. Wes, Vitaly Vasilevko, David H. Cribbs, Frank M. LaFerla - The Journal of Immunology 2011 cited by 451

  8. Intraneuronal Aβ Causes the Onset of Early Alzheimer’s Disease-Related Cognitive Deficits in Transgenic Mice

    Authors: Lauren M. Billings, Salvatore Oddo, Kim N. Green, James L. McGaugh, Frank M. LaFerla - Neuron 2005 cited by 1,294

  9. Lipopolysaccharide-Induced Inflammation Exacerbates Tau Pathology by a Cyclin-Dependent Kinase 5-Mediated Pathway in a Transgenic Model of Alzheimer's Disease

    Authors: Masashi Kitazawa, Salvatore Oddo, Tritia R. Yamasaki, Kim N. Green, Frank M. LaFerla - Journal of Neuroscience 2005 cited by 689

  10. Synergistic Interactions between Aβ, Tau, and α-Synuclein: Acceleration of Neuropathology and Cognitive Decline

    Authors: Lani Clinton, Mathew Blurton‐Jones, Kristoffer Myczek, John Q. Trojanowski, Frank M. LaFerla - Journal of Neuroscience 2010 cited by 578

  11. Synaptic Impairment in Alzheimer’s Disease: A Dysregulated Symphony

    Authors: Stefânia Forner, David Baglietto‐Vargas, Alessandra Cadete Martini, Laura Trujillo‐Estrada, Frank M. LaFerla - Trends in Neurosciences 2017 cited by 449

  12. Nicotinamide Restores Cognition in Alzheimer's Disease Transgenic Mice via a Mechanism Involving Sirtuin Inhibition and Selective Reduction of Thr231-Phosphotau

    Authors: Kim N. Green, Joan S. Steffan, Hilda Martínez‐Coria, Xuemin Sun, Steven S. Schreiber, Leslie M. Thompson, Frank M. LaFerla - Journal of Neuroscience 2008 cited by 402

  13. Neural stem cells improve cognition via BDNF in a transgenic model of Alzheimer disease

    Authors: Mathew Blurton‐Jones, Masashi Kitazawa, Hilda Martínez‐Coria, Nicholas A. Castello, Franz-Josef Müller, Jeanne F. Loring, Tritia R. Yamasaki, Wayne W. Poon, Kim N. Green, Frank M. LaFerla - National Academy of Sciences, Proceedings of the National Academy of Sciences 2009 cited by 869

  14. Progesterone and Estrogen Regulate Alzheimer-Like Neuropathology in Female 3xTg-AD Mice

    Authors: Jenna C. Carroll, Emily R. Rosario, Lilly Chang, Frank Z. Stanczyk, Salvatore Oddo, Frank M. LaFerla, Christian J. Pike - Journal of Neuroscience 2007 cited by 365

  15. Glucocorticoids Increase Amyloid-β and Tau Pathology in a Mouse Model of Alzheimer’s Disease

    Authors: Kim N. Green, Lauren M. Billings, Benno Roozendaal, James L. McGaugh, Frank M. LaFerla - Journal of Neuroscience 2006 cited by 614

  16. Sustained Interleukin-1β Overexpression Exacerbates Tau Pathology Despite Reduced Amyloid Burden in an Alzheimer's Mouse Model

    Authors: Simantini Ghosh, Michael D. Wu, Solomon S. Shaftel, Stephanos Kyrkanides, Frank M. LaFerla, John A. Olschowka, M. Kerry O’Banion - Journal of Neuroscience 2013 cited by 374

  17. Calcium dyshomeostasis and intracellular signalling in alzheimer's disease

    Authors: Frank M. LaFerla - Nature reviews. Neuroscience 2002 cited by 990

  18. Intermittent fasting and caloric restriction ameliorate age-related behavioral deficits in the triple-transgenic mouse model of Alzheimer's disease

    Authors: Veerendra K. Madala Halagappa, Zhihong Guo, Michelle Pearson, Yasuji Matsuoka, Roy G. Cutler, Frank M. LaFerla, Mark P. Mattson - Neurobiology of Disease 2007 cited by 576

  19. A Trem2R47H mouse model without cryptic splicing drives age- and disease-dependent tissue damage and synaptic loss in response to plaques

    Authors: Kristine M. Tran, Shimako Kawauchi, Enikö A. Kramár, Narges Rezaie, Heidi Yahan Liang, Jasmine Sakr, Ángela Gómez-Arboledas, Miguel A. Arreola, Celia da Cunha, Jimmy Phan, Shuling Wang, Sherilyn Collins, Amber Walker, Kai‐Xuan Shi, Jonathan Neumann, Ghassan Filimban, Zechuan Shi, Giedre Milinkeviciute, Dominic I. Javonillo, Katelynn Tran, Magdalena Gantuz, Stefânia Forner, Vivek Swarup, Andrea J. Tenner, Frank M. LaFerla, Marcelo A. Wood, A Mortazavi, Grant R. MacGregor, Kim N. Green - Molecular Neurodegeneration 2023 cited by 50

  20. Animal Models of Alzheimer Disease

    Authors: Frank M. LaFerla, K. N. Green - Cold Spring Harbor Perspectives in Medicine 2012 cited by 423

  21. Microglial Cx3cr1 knockout prevents neuron loss in a mouse model of Alzheimer's disease

    Authors: Martin Fuhrmann, Tobias Bittner, Christian Jung, Steffen Burgold, Richard Page, Gerda Mitteregger, Christian Haass, Frank M. LaFerla, Hans A. Kretzschmar, Jochen Herms - Nature Neuroscience 2010 cited by 556

  22. Aβ inhibits the proteasome and enhances amyloid and tau accumulation

    Authors: Bertrand P. Tseng, Kim N. Green, Julie L. Chan, Mathew Blurton‐Jones, Frank M. LaFerla - Neurobiology of Aging 2007 cited by 376

  23. Altered Expression of Diabetes-Related Genes in Alzheimer's Disease Brains: The Hisayama Study

    Authors: Masaaki Hokama, Sugako Oka, Julio Leon, Toshiharu Ninomiya, Hiroyuki Honda, Kensuke Sasaki, Toru Iwaki, Tomoyuki Ohara, Tomio Sasaki, Frank M. LaFerla, Yutaka Kiyohara, Yusaku Nakabeppu - Cerebral Cortex 2013 cited by 328

  24. Model organism development and evaluation for late‐onset Alzheimer's disease: MODEL‐AD

    Authors: Adrian L. Oblak, Stefânia Forner, Paul R. Territo, Michael Sasner, Gregory W. Carter, Gareth R. Howell, Stacey J. Sukoff Rizzo, Benjamin A. Logsdon, Lara M. Mangravite, A Mortazavi, David Baglietto‐Vargas, Kim N. Green, Grant R. MacGregor, Marcelo A. Wood, Andrea J. Tenner, Frank M. LaFerla, Bruce T. Lamb, and The MODEL‐AD - Alzheimer s & Dementia Translational Research & Clinical Interventions 2020 cited by 109